Send feedback

GP1BA p.Ser441fs

c.1322_1344del · rs770089708 · VCV435346

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 6 submitters
Consequence
frameshift
predicted LoF
gnomAD v4.1
Common
common (popmax 25.3%, sas) — too common for a highly-penetrant pathogenic allele
Conditions
4
nonarteritic anterior ischemic optic neuropathy, susceptibility to

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDescapespremature termination codon in the last exon (2 of 2) — the truncated protein is likely expressed. PVS1 input, not an applied code
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP -4.6GERP -2.2
Overall
CADD22.0PHRED · no single calibrated threshold — expert panels disagree
Region caveats
Repeat contexttandemCCAAGCCCGACCACCCCAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCGGAGCCCACT simple repeat · ambiguous alignment · confidence, not pathogenicity

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 25.3% South Asian · 13,105/51,786 alleles
Filtering AF 24.9% ClinGen BA1/BS1 input FAF95, joint · FAF99 24.8%
Overall 16.2% 71,973/444,900 alleles · common
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 49.5% 2
South Asiangrpmax 25.3% 4
East Asian 24.9% 4
Admixed American 19.4% 5
Remaining individualsnot grpmax-eligible 17.2% 6
African / African-American 16.7% 6
Finnishnot grpmax-eligible 14.2% 7
European (non-Finnish) 13.9% 7
Middle Eastern 11.2% 9
Ashkenazi Jewishnot grpmax-eligible 9.26% 11

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
GP1BA
Protein
p.Ser441fs
Coding
c.1322_1344del
MANE Select
NM_000173
dbSNP
rs770089708
Type
Deletion
Location
chr17:4933926 (GRCh38)
Gene constraint
LOEUF 1.289 · pLI 0.10 (gnomAD)
Structure
AlphaFold pLDDT 64.65 · 22 PDB
Residue 441
the 'disordered' region
Full GP1BA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gp1ba-p-ser441fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown